End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-16 pm EDT
5-day change
1st Jan Change
7.89
CNY
+1.54%
-5.96%
-9.73%
Tranche Update on Innovation Medical Management Co., Ltd.'s Equity Buyback Plan announced on January 20, 2021.
April 01, 2021 at 12:00 pm EDT
From January 19, 2021 to March 31, 2021, the company has repurchased 4,939,498 shares, representing 1.09% for CNY 29.76 million. With this, the company has completed the repurchase of 4,939,498 shares, representing 1.09% for CNY 29.76 million under the buyback announced on January 20, 2021.
Innovative Medical Management Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 26
CI
Innovative Medical Management Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 12
CI
Jiangsu Futian Rehabilitation Hospital Co., Ltd. announced that it expects to receive CNY 10 million in funding from Innovative Medical Management Co.,Ltd.
Jan. 25
CI
Innovative Medical Management Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-27
CI
Innovative Medical Management Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-17
CI
China and Hong Kong stocks close flat ahead of May manufacturing data
23-05-30
RE
China, Hong Kong stocks fall ahead of May manufacturing data
23-05-30
RE
Innovative Medical Management Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-27
CI
Shanghai 2345 Financial Leasing Co., Ltd. acquired a 9.09% stake in Innovative Medical Management Co.,Ltd. from Shanghai Kanghan Investment Management Center (Limited Partnership).
23-01-03
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-27
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-19
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-29
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-29
CI
Innovation Medical Management Co., Ltd. Announces Executive Changes
22-03-22
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-29
CI
Innovation Medical Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
21-08-27
CI
Jiangsu Futian Rehabilitation Hospital Co., Ltd. announced that it expects to receive CNY 10 million in funding from Innovation Medical Management Co., Ltd.
21-06-06
CI
Innovation Medical Management Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021
21-04-27
CI
Haining Kanghua Hospital Co., Ltd. announced that it expects to receive CNY 93 million in funding from Innovation Medical Management Co., Ltd.
21-04-25
CI
Tranche Update on Innovation Medical Management Co., Ltd.'s Equity Buyback Plan announced on January 20, 2021.
21-04-19
CI
Innovation Medical Management Co., Ltd.'s Equity Buyback announced on January 20, 2021, has expired with 7,758,700 shares, representing 1.71% for CNY 48.4 million.
21-04-17
CI
Tranche Update on Innovation Medical Management Co., Ltd.'s Equity Buyback Plan announced on January 20, 2021.
21-04-01
CI
Innovation Medical Management Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
21-01-19
CI
Jiangsu Futian Rehabilitation Hospital Co., Ltd. announced that it expects to receive CNY 20 million in funding from Innovation Medical Management Co., Ltd.
21-01-18
CI
Innovation Medical Management Co., Ltd. authorizes a Buyback Plan.
21-01-18
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Innovative Medical Management Co Ltd, formerly Pure Pearl Group Co., Ltd., is a China-based company principally engaged in the provision of medical services. Through owning the interests of its subsidiaries, the Company provides medical services in key specialists, including burns, lumbar disc, breast, neurology, cardiovascular medicine and others, as well as in special specialists, such as obstetrics and gynecology, urology, nephrology and endoscopy, ophthalmology and others. The Company is also engaged in the cultivation, processing and distribution of pearls. Its products include pearls, accessories and health care products. The Company mainly conducts its businesses in domestic market.
More about the company
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1